for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
  Medtech Insight
  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 1876-8008
   Published by Informa plc Homepage  [13 journals]
  • Obesity 2015: Less Invasive Options Will Drive Growth In Market Hungry For
           Solutions
    • Abstract: Nearly half of the world’s adult population will be overweight or obese by 2030 and obesity is tied to more than 40 diseases. Enterprising companies are heeding the call with increasingly less invasive weight loss devices, while an amenable regulatory environment means the marketplace will welcome some of these innovations in 2015.
      PubDate: Fri, 27 Mar 2015 00:05:40 -040
       
  • New Injectables For Knee OA Fuel US Joint Fluid Market
    • Abstract: Although several factors have recently slowed growth in the US market for joint fluid replacement, it remains large and vastly underpenetrated with an estimated 15.8 million knee osteoarthritis patients who are hoping to delay the need for a total knee arthroplasty. With a growing number of products in the pipeline and increasing adoption of new single-injection products, the US joint fluid market is projected to increase from approximately $924.4 million in 2015 to more than $1.07 billion by 2019, a CAGR of 4%.
      PubDate: Fri, 27 Mar 2015 00:05:28 -040
       
  • Targeting The Tongue: Helius Medical’s Unique Approach To
           Neuromodulation Tested In Trials
    • Abstract: Neuromodulation start-up Helius Medical Technologies is employing a simpler, more primal connection to send potentially therapeutic signals to the brain – the tongue. The company is entering pivotal clinical trials to test the technology in select patients with traumatic balance disorder and traumatic brain injury, and evaluating the device for use in patients with multiple sclerosis.
      PubDate: Fri, 27 Mar 2015 00:05:18 -040
       
  • AF Ablation Procedures Driving CRM Market Expansion
    • Abstract: Cardiac rhythm management device sales in the US are projected to grow at a compound annual rate of 2.9%, increasing to an estimated $8.2 billion in the year 2019. Two of the fastest growing sectors of the market, electrophysiology and ablation devices, will be driven by a 10% to 20% growth in the number of patients treated for atrial fibrillation.
      PubDate: Fri, 27 Mar 2015 00:05:01 -040
       
  • Intact Vascular: Optimizing Balloon Angioplasty For Peripheral Arterial
           Disease
    • Abstract: An alternative to traditional stents to treat peripheral arterial disease, Intact Vascular Inc.’s Tack Endovascular System uses multiple, small nitinol implants to reduce metal exposure when treating peripheral arterial disease. The Tack system minimizes the metal that is left in the artery compared with a stent and also decreases the vessel inflammation associated with stents.
      PubDate: Fri, 27 Mar 2015 00:00:49 -040
       
  • Major Players Keep Remote Patient Monitoring Moving Forward
    • Abstract: Medtronic and Roche have made important moves in the remote monitoring market with new partnerships designed to enhance their places in telemedicine, which continues to be an important point of emphasis for providers. Meanwhile, AliveCor, a young company with groundbreaking cardiology technology for the smartphone, has reached an important milestone in Europe.
      PubDate: Fri, 27 Mar 2015 00:00:38 -040
       
  • Medtronic’s VenaSeal Closure System Receives
           FDA Approval For Treating Chronic Venous Disease
    • Abstract: Adding to its product portfolio for treating superficial venous reflux, Medtronic has now received US approval for a more minimally invasive device, the VenaSeal closure system, which uses adhesive injections to seal the diseased vein in select patients with chronic venous insufficiency. Superficial venous reflux can lead to symptomatic varicose veins.
      PubDate: Fri, 27 Mar 2015 00:00:32 -040
       
  • ECR 2015: Radiology Trends To Watch
    • Abstract: Five important trends emerged at the European Congress of Radiology (ECR) meeting held in Vienna in March that could shape the future of radiology. Trends to watch include the growing importance of quantitative imaging, Big Data management, the rebirth of ultrasound, miniaturization, as well as a trend toward more cost-effective, “mid-range” scanners.
      PubDate: Fri, 27 Mar 2015 00:00:27 -040
       
  • Medical Device Deals Update, March 2015
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced February-March 2015.
      PubDate: Fri, 27 Mar 2015 00:00:19 -040
       
  • 3Scan: 3D Models Of Tissue Biology
    • Abstract: Pathology workflow hasn’t changed much since the field began some 100 years ago – tissue is sectioned with a microtome, mounted to a glass slide, and placed into a microscope – but the process could dramatically change for the better, thanks to the digital Knife Edge Scanning Microscope from 3Scan Inc. What has traditionally been a manual and qualitative process, KESM facilitates with high throughput, quantified image analysis and computation of tissue sliced as thin as 1 micron.
      PubDate: Fri, 27 Mar 2015 00:00:11 -040
       
  • Medtech Execs On The Move, March 2015
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Fri, 27 Mar 2015 00:00:01 -040
       
  • US Heart Valve Treatments Market Fueled By New Transcatheter Valves
    • Abstract: The US heart valve treatments market will reach $1.7 billion by 2019, driven by advances in percutaneous heart valve repair and replacement products and a growing number of competitors entering this space. With US sales of transcatheter aortic valve replacement systems set to almost triple in the next several years, the combined US market for products to treat heart valve disorders is expected to grow at a CAGR of 7.7%.
      PubDate: Fri, 27 Feb 2015 00:05:23 -050
       
  • Companies Forge Ahead With New Devices, Studies, And Funding For
           Treatment-Resistant Hypertension
    • Abstract: With Medtronic planning to submit an IDE application to the FDA soon to conduct a new US trial of its renal denervation technology, companies and investors alike remain optimistic about finding an effective device-based therapy for treatment-resistant hypertension. Two smaller players in this space – Rox Medical and Verve Medical – are also forging ahead, due to recently published encouraging study results for Rox’s stent-like implant, Coupler, and a nearly $2 million Series B1 round to fund further clinical trials of Verve’s Phoenix RF energy device.
      PubDate: Fri, 27 Feb 2015 00:05:18 -050
       
  • Alzheimer’s Disease: Moving Toward The Era Of Diagnostic Certainty
    • Abstract: With more than 13 million people in the US expected to have Alzheimer’s disease (AD) by 2050, an increasing number of companies are focused on developing reliable AD diagnostics designed to facilitate early detection and treatment. Although the field remains in its relative infancy, researchers are gaining greater diagnostic certainty through a combination of diagnostic approaches, and over the next decade, the AD diagnostics market is projected to reach a US market value of at least $1 billion to $3 billion per year.
      PubDate: Fri, 27 Feb 2015 00:05:13 -050
       
  • The Regenerative Market Brings The Future Closer
    • Abstract: A clear sign the regenerative medicine and therapy market is making considerable progress comes from the amount of investor funding pouring into the space, and although a lot of the technology is still spoken about in the future tense, a variety of new companies are bringing the future much closer. An additional hallmark of the market is the role device companies are finding for themselves in an industry primarily lead by pharmaceutical businesses.
      PubDate: Fri, 27 Feb 2015 00:05:00 -050
       
  • TiaLinx: Developing The First Non-Contact, Non-Ionizing Scanner To Detect
           Breast Cancer
    • Abstract: With the breast cancer screening population expected to reach almost 250 million by 2018, TiaLinx says its new AR60-A scanner is the first non-contact, high-resolution imaging technology that does not emit ionizing radiation, and is an affordable screening alternative for the 210,000 primary care physicians in the US and significantly more worldwide.
      PubDate: Fri, 27 Feb 2015 00:00:11 -050
       
  • Micro Interventional Devices’ Permaseal Moves
           Closer To Regulatory Approval With Early CE Trial Results
    • Abstract: Preliminary 30-day results from the Secure Transapical Access and Closure Study (STASIS) suggest Micro Interventional Devices’ Permaseal device, a transapical access and closure device for structural heart repair, provides safe and effective hemostasis and wound closure after transapical transcatheter aortic valve replacement. The company estimates the worldwide market potential for the device is more than $3 billion annually.
      PubDate: Fri, 27 Feb 2015 00:00:09 -050
       
  • Novocure Advances Tumor Treating Fields Technology For Patients With Newly
           Diagnosed Glioblastoma
    • Abstract: Novocure’s tumor treating fields technology offers hope to the 10,000 to 12,000 patients in the US diagnosed with glioblastoma multiforme (GBM), the most common and deadliest form of malignant primary brain tumor. The EF-14 Phase III clinical trial evaluating the company’s Optune device for newly diagnosed GBM was terminated due to early success, and in December 2014, the FDA approved an IDE supplement allowing all control patients in the trial to receive the treatment.
      PubDate: Fri, 27 Feb 2015 00:00:07 -050
       
  • Medtech Execs On The Move, February 2015
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Fri, 27 Feb 2015 00:00:06 -050
       
  • Medical Device Deals Update, February 2015
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced January-February 2015.
      PubDate: Fri, 27 Feb 2015 00:00:03 -050
       
  • Laurimed: In-Office Removal Of Nasal Polyps
    • Abstract: Laurimed LLC has developed PolypVac, a suction-powered microdebrider for treating nasal polyposis, an inflammatory response to chronic inflammation. It is designed to be used in an ENT’s office in a 15-minute procedure performed under local anesthesia.
      PubDate: Fri, 27 Feb 2015 00:00:02 -050
       
  • Centerline Biomedical: 3D Navigation For Interventional Vascular
           Procedures
    • Abstract: Centerline Biomedical Inc.’s 3D navigation system for interventional vascular procedures is designed to provide physicians with greater visualization than fluoroscopy,and to reduce caregivers and patients exposure to harmful radiation.
      PubDate: Fri, 27 Feb 2015 00:00:01 -050
       
  • Spine Market: Making A Comeback
    • Abstract: In spite of increasing price pressure, the $9 billion global spine market is projected to see low-single-digit growth in the next few years. Driving growth are the pure-play spine companies targeting high-growth segments such as minimally invasive surgery, expandable interbody cases, cervical discs, and deformity.
      PubDate: Fri, 30 Jan 2015 00:05:57 -050
       
  • Active Lifestyles And New Surgical Techniques Driving Sports Medicine
           Market
    • Abstract: Although the US sports medicine market is dominated by conservative care treatments, new surgical techniques, arthroscopy products and surgical implants are fueling growth in the market, which is projected to reach almost $15.5 billion by 2018. Industry consolidation and dealmaking among orthopedic manufacturers has yielded several partnerships and M&As that have included a sports medicine element.
      PubDate: Fri, 30 Jan 2015 00:05:50 -050
       
  • Medtech 2014: M&A, IPOs Bounce Back As Industry Glimpses Future
           Business Models
    • Abstract: Healthy market growth, the biggest ever M&A deal, a record number of billion-dollar takeovers, and the IPO market in impressive bounce-back…2014 was a year of superlatives for the global medtech industry. But with more expected of manufacturers while health care spending remains in the doldrums and demand for care rises, the long-term medtech winners will be those who can forecast how and where to make an impact on both costs and patient outcomes.
      PubDate: Fri, 30 Jan 2015 00:05:12 -050
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015